E
Eugene Technology Co Ltd
KOSDAQ:084370
Eugene Technology Co Ltd
KOSDAQ:084370
Price:
31 550
KRW
3.78%
Market Cap:
701.8B
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Eugene Technology Co Ltd
31550
+1150 (+3.78%)
| 52 Week Range |
30 400
57 600
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Eugene Technology Co Ltd
Balance Sheet
Balance Sheet Decomposition
Eugene Technology Co Ltd
Eugene Technology Co Ltd
| Current Assets | 358.1B |
| Cash & Short-Term Investments | 233.6B |
| Receivables | 20.6B |
| Other Current Assets | 103.9B |
| Non-Current Assets | 143.5B |
| Long-Term Investments | 1.4B |
| PP&E | 96.9B |
| Intangibles | 37.4B |
| Other Non-Current Assets | 7.9B |
| Current Liabilities | 84B |
| Accounts Payable | 15.6B |
| Accrued Liabilities | 2.6B |
| Other Current Liabilities | 65.8B |
| Non-Current Liabilities | 47.8B |
| Long-Term Debt | 6.3B |
| Other Non-Current Liabilities | 41.5B |
Balance Sheet
Eugene Technology Co Ltd
Eugene Technology Co Ltd
Currency: KRW
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
32 073
|
42 678
|
50 090
|
28 049
|
23 593
|
21 296
|
22 886
|
14
|
2
|
43 583
|
|
| Cash |
1
|
18
|
2
|
6
|
4
|
4
|
2
|
6
|
2
|
43 583
|
|
| Cash Equivalents |
32 072
|
42 660
|
50 088
|
28 043
|
23 589
|
21 292
|
22 884
|
20
|
0
|
0
|
|
| Short-Term Investments |
89 275
|
95 871
|
117 743
|
54 094
|
50 654
|
78 276
|
68 380
|
109 783
|
111 509
|
140 562
|
|
| Total Receivables |
12 861
|
2 488
|
7 307
|
44 606
|
16 029
|
11 776
|
8 366
|
19 896
|
20 789
|
10 942
|
|
| Accounts Receivables |
12 539
|
1 860
|
7 282
|
44 596
|
15 989
|
11 735
|
8 316
|
19 853
|
20 714
|
9 675
|
|
| Other Receivables |
322
|
628
|
25
|
10
|
40
|
41
|
50
|
42
|
75
|
1 268
|
|
| Inventory |
6 772
|
8 113
|
6 038
|
19 508
|
54 786
|
34 237
|
56 206
|
78 437
|
117 125
|
102 172
|
|
| Other Current Assets |
717
|
481
|
471
|
10 819
|
4 172
|
3 047
|
4 502
|
2 856
|
1 995
|
2 652
|
|
| Total Current Assets |
141 698
|
149 632
|
181 648
|
157 076
|
149 234
|
148 632
|
160 340
|
240 979
|
297 304
|
299 912
|
|
| PP&E Net |
35 905
|
36 835
|
37 039
|
43 198
|
66 407
|
78 072
|
86 235
|
94 914
|
92 315
|
92 553
|
|
| PP&E Gross |
35 905
|
36 835
|
37 039
|
43 198
|
66 407
|
78 072
|
86 235
|
94 914
|
92 315
|
92 553
|
|
| Accumulated Depreciation |
6 367
|
8 318
|
10 466
|
12 677
|
15 553
|
23 315
|
30 267
|
40 614
|
53 886
|
59 770
|
|
| Intangible Assets |
8 925
|
10 225
|
14 337
|
41 934
|
41 560
|
38 655
|
35 462
|
33 179
|
31 589
|
30 316
|
|
| Goodwill |
160
|
160
|
160
|
16 447
|
8 615
|
4 675
|
4 403
|
4 783
|
5 102
|
5 188
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
100
|
0
|
0
|
|
| Long-Term Investments |
1 902
|
2 352
|
3 230
|
2 982
|
2 684
|
3 577
|
2 771
|
2 698
|
2 058
|
1 760
|
|
| Other Long-Term Assets |
2 382
|
2 388
|
3 258
|
4 210
|
4 956
|
4 740
|
4 749
|
6 238
|
5 645
|
7 261
|
|
| Other Assets |
160
|
160
|
160
|
16 447
|
8 615
|
4 675
|
4 403
|
4 783
|
5 102
|
5 188
|
|
| Total Assets |
190 972
N/A
|
201 592
+6%
|
239 672
+19%
|
265 846
+11%
|
273 456
+3%
|
278 351
+2%
|
293 960
+6%
|
382 892
+30%
|
434 014
+13%
|
436 990
+1%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
7 341
|
8 579
|
5 776
|
17 357
|
11 028
|
7 244
|
14 000
|
21 899
|
16 438
|
17 190
|
|
| Accrued Liabilities |
1 454
|
938
|
2 309
|
2 399
|
981
|
1 134
|
851
|
1 088
|
3 568
|
2 091
|
|
| Short-Term Debt |
348
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1 033
|
1 241
|
5 920
|
5 852
|
4 695
|
|
| Other Current Liabilities |
7 184
|
6 068
|
17 072
|
11 030
|
21 007
|
14 082
|
16 281
|
32 893
|
51 712
|
32 785
|
|
| Total Current Liabilities |
16 327
|
15 585
|
25 156
|
30 786
|
33 017
|
23 493
|
32 373
|
61 800
|
77 570
|
56 762
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
3 765
|
5 121
|
1 330
|
120
|
84
|
|
| Minority Interest |
1 041
|
1 254
|
838
|
1 169
|
2 662
|
7 702
|
14 074
|
17 206
|
22 437
|
23 628
|
|
| Other Liabilities |
1 449
|
2 107
|
2 775
|
3 869
|
3 732
|
5 836
|
7 464
|
9 021
|
9 622
|
11 668
|
|
| Total Liabilities |
18 818
N/A
|
18 946
+1%
|
28 770
+52%
|
35 824
+25%
|
39 410
+10%
|
40 797
+4%
|
59 031
+45%
|
89 357
+51%
|
109 749
+23%
|
92 143
-16%
|
|
| Equity | |||||||||||
| Common Stock |
10 863
|
11 186
|
11 458
|
11 458
|
11 458
|
11 458
|
11 458
|
11 458
|
11 458
|
11 458
|
|
| Retained Earnings |
158 976
|
176 095
|
204 193
|
226 595
|
226 724
|
226 467
|
225 524
|
280 875
|
314 022
|
331 736
|
|
| Additional Paid In Capital |
623
|
297
|
23
|
23
|
23
|
23
|
23
|
945
|
23
|
23
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
661
|
561
|
1 006
|
784
|
1 032
|
|
| Treasury Stock |
2 385
|
8 995
|
8 833
|
8 618
|
0
|
0
|
0
|
0
|
0
|
12 916
|
|
| Other Equity |
4 078
|
4 063
|
4 062
|
564
|
4 159
|
1 054
|
2 637
|
750
|
2 022
|
13 514
|
|
| Total Equity |
172 154
N/A
|
182 646
+6%
|
210 903
+15%
|
230 022
+9%
|
234 046
+2%
|
237 554
+1%
|
234 929
-1%
|
293 534
+25%
|
324 265
+10%
|
344 847
+6%
|
|
| Total Liabilities & Equity |
190 972
N/A
|
201 592
+6%
|
239 672
+19%
|
265 846
+11%
|
273 456
+3%
|
278 351
+2%
|
293 960
+6%
|
382 892
+30%
|
434 014
+13%
|
436 990
+1%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
23
|
22
|
22
|
22
|
22
|
22
|
22
|
22
|
22
|
22
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
